Main effects–hazard ratios | Overweight and obesity (BMI) | Central obesity (Waist circumference) | Fatty liver |
---|---|---|---|
Model 1 | |||
 Increased adiposity | 2.15 (2.06‒2.25) | 1.78 (1.71‒1.85) | 2.47 (2.37‒2.57) |
 Increased inflammation | 1.16 (1.07‒1.25) | 1.16 (1.09‒1.23) | 1.15 (1.09‒1.22) |
 Joint effect | 2.61 (2.48‒2.75) | 2.10 (2.00‒2.20) | 2.84 (2.70‒2.97) |
 RERI | 0.30 (0.17‒0.43) | 0.16 (0.05‒0.27) | 0.22 (0.08‒0.36) |
 AP | 0.12 (0.07‒0.16) | 0.08 (0.03‒0.13) | 0.08 (0.03‒0.13) |
 S | 1.23 (1.12‒1.35) | 1.17 (1.05‒1.31) | 1.14 (1.04‒1.23) |
 Attributable proportion, (%) | |||
  Increased adiposity | 71.43 | 70.91 | 79.89 |
  Increased inflammation | 9.94 | 14.55 | 8.15 |
  Additive interaction | 18.63 | 14.54 | 11.96 |
Model 2 | |||
 Increased adiposity | 1.77 (1.69‒1.85) | 1.67 (1.61‒1.74) | 2.03 (1.95‒2.12) |
 Elevated inflammation | 1.14 (1.06‒1.23) | 1.15 (1.08‒1.21) | 1.12 (1.07‒1.18) |
 Joint effect | 2.08 (1.97‒2.19) | 1.94 (1.85‒2.03) | 2.30 (2.19‒2.42) |
 RERI | 0.17 (0.05‒0.28) | 0.12 (0.02‒0.23) | 0.15 (0.02‒0.27) |
 AP | 0.08 (0.03‒0.14) | 0.06 (0.01‒0.12) | 0.06 (0.01‒0.11) |
 S | 1.19 (1.05‒1.34) | 1.15 (1.01‒1.30) | 1.13 (1.02‒1.24) |
 Attributable proportion, (%) | |||
 Increased adiposity | 71.30 | 71.28 | 79.23 |
 Increased inflammation | 12.96 | 15.96 | 9.23 |
 Additive interaction | 15.74 | 12.76 | 11.54 |